Navigation Links
AACR congratulates recipients of minority-serving institution in cancer research awards
Date:3/25/2011

ications in cancer progression
Abstract #1733. Therapeutic significance of ERαPELP1 axis in blocking endocrine therapy resistance
Abstract #2297. ERβ agonists reduce letrozole resistant breast cancer cell growth and diminish aromatase expression and activity

  • Cynthia M. van Golen, Ph.D., Delaware State University, Dover, Del.

Abstract #2085. Reactive oxygen species promote signaling in neuroblastoma cells
Abstract #2924. IGF-IR inhibition induces MAPK signaling in prostate carcinoma cells
Abstract #2425. Mechanisms of neuroblastoma metastasis to bone
Abstract #1435. Analyzing the role of CXCR and IGF-IR in modulating actin dynamics in neuroblastoma cells

  • Pablo E. Vivas-Meja, Ph.D., University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico

Abstract #1706. Microarray analysis of gene expression reveals that several mTOR related genes are upregulated in cisplatin resistant ovarian cancer cells
Abstract #937. Molecular dynamics of SrcS17 activation in chronic stress-induced tumor growth
Abstract #1735. Silencing survivin splice variant 2B leads to antitumor activity in taxane-resistant ovarian cancer
Abstract #1618. Erythropoietin meets a new receptor
Abstract #4457. In search of a novel EPO receptor: The clinical significance of the Eph connection

  • Clement G. Yedjou, Ph.D., Jackson State University, Jackson, Miss.

Abstract #1322. Molecular mechanisms of high glucose-induced toxicity in human breast adenocarcinoma (Mcf-7) cells
Abstract #4209. Genotoxic effects of arsenic trioxide-induced oxidative stress in human hepatocellular carcinoma (HepG2) cells

  • Beatriz Zayas, Ph.D., Universidad Metropolitana, San Juan, Puerto Rico

Abstract #4474. Cellular effects of fluorescent quinolinium drugs on normal lymphoblast and A431 carcinoma cells Abstract #1342. Effects of the plasticizer metabolite 2 ethyl
'/>"/>
Contact: Michele Sharp
Michele.Sharp@aacr.org
267-646-0622
American Association for Cancer Research
Source:Eurekalert

Page: 1 2 3 4 5 6 7

Related biology news :

1. AACR congratulates William S. Dalton on 2010 Leadership in Personalized Medicine Award
2. The AACR congratulates its members elected to the Institute of Medicine
3. Elsevier congratulates Royal Australian Chemical Institutes Athel Beckwith Lectureship winner
4. The American Association for Cancer Research congratulates Margaret Hamburg, M.D.
5. GSA congratulates 2008 award winners
6. 2011 Harold M. Weintraub Graduate Student Award recipients announced
7. Vilcek Foundation names recipients of 2011 Vilcek Prizes in Biomedical Science
8. PNAS announces 6 2010 Cozzarelli Prize recipients
9. Academy of Science-St. Louis announces recipients of Outstanding St. Louis Scientist Awards
10. American Society of Agronomy announces award recipients
11. Biophysical Society names 2011 award recipients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... leaves, photosystem 1 (PS1) absorbs light and its ... carbon dioxide to biomass. Photovoltaic devices, mostly build ... but produce electricity. One approach for the development ... the semi-conductor with the isolated membrane protein complexes ... a highly stable PS1 from thermophilic cyanobacteria that ...
(Date:8/19/2014)... to decrease China,s increasing caesarean section rate, suggests a ... An International Journal of Obstetrics and Gynaecology (BJOG) . ... rates in the world. Of 16 million babies born ... exact rate is not known, the current Chinese language ... rates ranging from 36% to 58%. However, before the ...
(Date:8/19/2014)... This news release is available in German . ... power are inherently intermittent energy sources. If a large amount ... in the future, excess energy will have to be stored ... for. However, existing storage capacities are far from adequate for ... better technologies. One important focus lies on battery systems that ...
Breaking Biology News(10 mins):A semi-artificial leaf faster than 'natural' photosynthesis 2Is China's 50 percent cesarean section delivery rate too high? 2Is China's 50 percent cesarean section delivery rate too high? 3Asian inventions dominate energy storage systems 2Asian inventions dominate energy storage systems 3
... A) today announced that its breakthrough Human Genome CGH ... Peter MacCallum Cancer Centre in a three-year study designed ... lining of the chest, the abdominal cavity and around ... Due to its active mining and manufacturing of asbestos ...
... The human fossil evidence from the Mladec Caves in Moravia, ... proven for the first time, through modern radiocarbon dating, to ... modern humans in Europe. , A team of researchers from ... Vienna in Austria and from the Washington University in St. ...
... Studying phage, a primitive class of virus that infects ... researchers have gained insight into the driving force behind ... in the past to occur through the release of ... all phages (also known as bacteriophages) are formed of ...
Cached Biology News:Agilent Technologies new genome analysis technology set to accelerate Australia fight against mesothelioma 2Oldest cranial, dental and postcranial fossils of early modern European humans confirmed 2Basis for DNA ejection from single phage particles 2
(Date:8/19/2014)... (PRWEB) August 19, 2014 Robin Williams’ ... disease can take on an individual. Symptoms range ... facial expression, problems swallowing and severe depression. Parkinson’s ... dying off of dopamine producing neurons of the brain. ... a disease that slowly and progressively gets worse, they ...
(Date:8/19/2014)... 2014 CSSi, the leader in patient recruitment ... formation of the company,s Medical and Clinical Advisory Board ... Dr. William E. Gannon, Jr. to the ... The MCAB, with Dr. Gannon,s leadership, will ... and set strategic goals for the advancement and development ...
(Date:8/19/2014)... 2014 /PRNewswire/ - iCo Therapeutics Inc. ("iCo" or "the ... of its Oral Amphotericin B (Oral Amp B) ... conducted by ImmuneCarta®, the immune monitoring business unit ... of Oral Amp B in reactivating latent HIV ... intensive treatment with antiretroviral therapy. ...
(Date:8/18/2014)... new therapy developed by researchers at the University ... and Columbia University Medical Center (CUMC) may help ... treatment. , The researchers demonstrated in a ... selectively inhibit blood vessel re-narrowing and simultaneously promote ... balloon catheter to open narrowed or blocked arteries. ...
Breaking Biology Technology:As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 2As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 3CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board 2CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board 3iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 2iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 3Selective therapy may improve artery repair after interventional cardiovascular procedures 2Selective therapy may improve artery repair after interventional cardiovascular procedures 3
... ... most complex toxicology study designs in South Korea , ... Cedar Knolls, NJ and Daejeon, South Korea (PRWEB) ... solutions and the developer of Pristima™ the premier preclinical solution on the market, is ...
... , , ABBOTT PARK, Ill., Aug. ... expansion of the company,s XIENCE V(R) USA post-approval study designed to ... Everolimus Eluting Coronary Stent System in a real-world clinical setting out ... from the XIENCE V USA trial to be eligible to cross ...
... , , , ... MON ) R&D pipeline is on the verge of a technology ... for growers and has the company poised to meet its goals ... and president, will tell investors today. , , ...
Cached Biology Technology:Korea Institute of Toxicology Implementing Xybion's Pristima™ 2Abbott Expands XIENCE V(R) USA Trial to Enroll Patients into Landmark Dual Anti-Platelet Therapy (DAPT) Trial 2Abbott Expands XIENCE V(R) USA Trial to Enroll Patients into Landmark Dual Anti-Platelet Therapy (DAPT) Trial 3Abbott Expands XIENCE V(R) USA Trial to Enroll Patients into Landmark Dual Anti-Platelet Therapy (DAPT) Trial 4Monsanto Is on the Verge of a Technology Explosion, Executives Tell Investors at Annual Field Event 2Monsanto Is on the Verge of a Technology Explosion, Executives Tell Investors at Annual Field Event 3Monsanto Is on the Verge of a Technology Explosion, Executives Tell Investors at Annual Field Event 4Monsanto Is on the Verge of a Technology Explosion, Executives Tell Investors at Annual Field Event 5Monsanto Is on the Verge of a Technology Explosion, Executives Tell Investors at Annual Field Event 6Monsanto Is on the Verge of a Technology Explosion, Executives Tell Investors at Annual Field Event 7
Mouse/Rat WNK1 Affinity Purified Polyclonal Ab...
Recalibration of HL-2000-CAL products...
The Zymo-Spin PI Fast-Spin column features durable polypropylene construction and is the same column featured in the His-Spin Protein Miniprep. Capacity is 800 l....
LAL Chromogenic Endpoint assay...
Biology Products: